Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nephros, Inc. - Common Stock (NQ:NEPH)

3.801 +0.911 (+31.53%)
Streaming Delayed Price Updated: 1:55 PM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nephros, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Nephros Announces CEO Retirement and Succession Plan
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Retirement
Nephros Schedules First Quarter 2023 Financial Results Conference Call
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Nephros Announces Preliminary Results for First Quarter 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros's Earnings: A Preview
 
Via Benzinga
Nephros Foresees 6% Revenue Decline In Q4
 
Via Benzinga
Nephros: Q2 Earnings Insights
  Nephros (NASDAQ:NEPH) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
Nephros and Donastar Announce Strategic Partnership
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Nephros Announces Results for Quarter Ended September 30, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Third Quarter 2022 Financial Results Conference Call
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
Gainers Cazoo Gr (NYSE:CZOO) stock rose 8.8% to $0.68 during Monday's after-market session. The market value of their outstanding shares is at $517.3 million. 
Via Benzinga
Nephros Appoints Joe Harris to Its Board of Directors
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
  
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
  
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
Nephros Announces Results for Quarter Ended June 30, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Second Quarter 2022 Financial Results Conference Call
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Stocks That Hit 52-Week Lows On Monday
On Monday, 149 companies reached new 52-week lows. 
Via Benzinga
Nephros Receives FDA 510(k) Clearance for HDF Assist Module
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.